Ghost Tree Capital as of Sept. 30, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 8.0 | $32M | 420k | 75.32 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 7.9 | $31M | 401k | 78.00 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 7.6 | $30M | 100k | 300.00 | |
| Immunomedics | 6.5 | $26M | 1.9M | 13.26 | |
| Blueprint Medicines (BPMC) | 6.1 | $24M | 325k | 73.47 | |
| Mirati Therapeutics | 5.4 | $21M | 275k | 77.91 | |
| Sage Therapeutics (SAGE) | 3.9 | $15M | 110k | 140.29 | |
| Biohaven Pharmaceutical Holding | 3.7 | $15M | 350k | 41.72 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 3.7 | $14M | 150k | 96.32 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 3.6 | $14M | 75k | 190.00 | |
| Amicus Therapeutics (FOLD) | 3.5 | $14M | 1.7M | 8.02 | |
| Axsome Therapeutics (AXSM) | 3.5 | $14M | 675k | 20.24 | |
| Invesco Curncyshs Brit Pnd S Brit Poun Strl (FXB) | 3.2 | $13M | 106k | 119.25 | |
| BioMarin Pharmaceutical (BMRN) | 3.2 | $13M | 185k | 67.40 | |
| Pacira Pharmaceuticals (PCRX) | 2.4 | $9.5M | 250k | 38.07 | |
| Iovance Biotherapeutics (IOVA) | 2.3 | $9.1M | 500k | 18.20 | |
| Adverum Biotechnologies | 2.0 | $7.9M | 1.5M | 5.45 | |
| Rocket Pharmaceuticals (RCKT) | 1.8 | $7.3M | 625k | 11.65 | |
| Athenex | 1.6 | $6.4M | 523k | 12.16 | |
| Argenx Se Sponsored Adr (ARGX) | 1.4 | $5.7M | 50k | 113.96 | |
| Fate Therapeutics (FATE) | 1.4 | $5.4M | 350k | 15.53 | |
| Turning Point Therapeutics I | 1.2 | $4.7M | 125k | 37.60 | |
| Momenta Pharmaceuticals | 1.2 | $4.5M | 350k | 12.96 | |
| Kadmon Hldgs | 1.1 | $4.4M | 1.8M | 2.52 | |
| Invesco Curncyshs Swiss Fran Swiss Franc (FXF) | 1.1 | $4.4M | 48k | 92.61 | |
| Milestone Pharmaceuticals (MIST) | 1.1 | $4.4M | 235k | 18.65 | |
| Aerie Pharmaceuticals | 1.1 | $4.3M | 225k | 19.22 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $4.3M | 1.5M | 2.87 | |
| Homology Medicines | 1.0 | $4.1M | 225k | 18.10 | |
| Reata Pharmaceuticals Cl A | 1.0 | $4.0M | 50k | 80.30 | |
| Arvinas Ord (ARVN) | 1.0 | $4.0M | 185k | 21.55 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $3.7M | 315k | 11.60 | |
| Dicerna Pharmaceuticals | 0.9 | $3.4M | 235k | 14.36 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $3.0M | 250k | 12.01 | |
| Orchard Therapeutics Ads | 0.7 | $2.9M | 243k | 11.88 | |
| Viewray (VRAYQ) | 0.6 | $2.4M | 825k | 2.90 | |
| Cymabay Therapeutics | 0.6 | $2.3M | 440k | 5.12 | |
| Avrobio Ord (AVRO) | 0.6 | $2.2M | 155k | 14.12 | |
| Chiasma | 0.5 | $1.9M | 383k | 4.95 | |
| Epizyme | 0.3 | $1.4M | 132k | 10.32 | |
| Solid Biosciences | 0.3 | $1.0M | 100k | 10.34 | |
| Dermira | 0.1 | $272k | 43k | 6.40 |
